Giving Up on Precision Oncology? Not So Fast!
Vanderbilt University Department of Medicine, Division of Hematology/Oncology, Nashville, Tennessee, USA.|Vanderbilt University Department of Biomedical Informatics, Nashville, Tennessee , USA.|Vanderbilt-Ingram Cancer Center, Nashville, Tennessee , USA.
J L
JL
Warner
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000235:genetics / Q000378:metabolism; D000066491:Clinical Decision-Making; D006801:Humans; D008495:Medical Oncology / Q000379:methods*; D025202:Molecular Diagnostic Techniques; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D018579:Patient Selection; D057285:Precision Medicine / Q000379:methods*; D011237:Predictive Value of Tests; D018570:Risk Assessment
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor